| Description | ER 50891 quarterhydrate is a potent RARα (retinoic acid receptor α) antagonist that markedly diminishes the inhibitory effects of ATRA (all-trans retinoic acid) on osteoblastogenesis induced by BMP 2 (bone morphogenetic protein 2) [1]. |
| molecular weight | 437.02 |
| Molecular formula | C29H24N2O2.1/4H2O |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |